Avirmax Biopharma

Our Product Pipeline

Avirmax Biopharma Inc. is currently in the process of using the rAAV delivery system to develop multiple rAAV candidates. 

Presented below are the different phases for each one of Avirmax Biopharma’s product pipelines:

  • Indication
  • Lead Design & Production
  • AAV - Vector
  • Biochemical
  • Potency
  • Preclinical
  • IND - Enabling
  • Phase 1
  • Commercial Rights
  • Milestone

Wet AMD incl. PCV

ABI-110
0%

Enrolling

GA / dry AMD

ABI-201
0%

IND 2H25

PDR

ABI-202
0%

IND 2H26

Glaucoma

ABI-902
0%

IND 2H26

AMD: Age-related macular degeneration
GA: Geographic atrophy
PCV: Polypoidal choroidal vasculopathy
PDR: Proliferative diabetic retinopathy